Dr. Tilly on Pola-R-CHP in an Asia Subpopulation of Patients With DLBCL
August 5th 2022Hervé Tilly, MD, PhD, discusses the efficacy of polatuzumab vedotin-piiq plus rituximab, cyclophosphamide, doxorubicin, and prednisone in an Asia subpopulation of patients with diffuse large B-cell lymphoma.
Read More